- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0053386

Sam Marino Labs Private Limited
About Sam Marino Labs Private Limited
Data last updated:
Sam Marino Labs Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 April 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74900UP2009PTC037115. Its GSTIN is 05AANCS2181E1ZF (Uttarakhand).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Shahana Afaq and Garima Sharma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C – 39 Sector – H Aliganj, Lucknow, Uttar Pradesh, India – 226024.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.13 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹1.58 Lakh (net margin 1.4%) and EBITDA of ₹1.58 Lakh (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 19% over five years.
Sam Marino Labs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0053386). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Sam Marino Labs
Contact details
Sam Marino Labs Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 39 Sector – H Aliganj, Lucknow, Uttar Pradesh, India – 226024
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sam Marino Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sam Marino Labs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sam Marino Labs Private Limited, buy the company report.
Financials of Sam Marino Labs Private Limited
FY 2024 filings availableSam Marino Labs Private Limited reported revenue of ₹1.13 Cr (up 23% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 23% growth in the latest year. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.58 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.58 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sam Marino Labs Private Limited, buy the company report.
Board of directors of Sam Marino Labs Private Limited
Sam Marino Labs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shahana Afaq | Director | 01 Apr 2023 | 3 Years 6 Months | Current |
| Garima Sharma | Director | 06 Apr 2009 | 17 Years 6 Months | Current |
Peer comparison
Sam Marino Labs Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pyramid Formulations Private Limited | ₹1.14 Cr (FY 2023) | 16.0% | Salem, Tamil Nadu, India | |||
| Inspride Lab Private Limited | ₹1.14 Cr (FY 2019) | 82.0% | Raipur, Chhattisgarh, India | |||
| Kapsin Pharma Private Limited | ₹1.14 Cr (FY 2025) | 8.0% | Ahmedabad, Gujarat, India | |||
| Coz Drug Marketing Services Private Limited | ₹1.13 Cr (FY 2024) | -10.0% | Lucknow, Uttar Pradesh, India | |||
| Sam Marino Labs Private Limitedthis company | ₹1.13 Cr (FY 2024) | ₹1.58 Lakh | 1.4% | 23.0% | Lucknow, Uttar Pradesh, India | |
| Kadam Pharma Private Limited | ₹1.13 Cr (FY 2025) | -88.0% | Aurangabad, Maharashtra, India | |||
| Index Therapeutics Private Limited | ₹1.13 Cr (FY 2024) | 11.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Sam Marino Labs Private Limited, buy the company report.
Auditor
Sam Marino Labs Private Limited is audited by T. NAGAR & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T. NAGAR & CO. | FY 2023 | 012198C |
Shareholding
The shareholding of Sam Marino Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sam Marino Labs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sam Marino Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sam Marino Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sam Marino Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AANCS2181E1ZF | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sam Marino Labs Private Limited, buy the company report.
Recent activity
Sam Marino Labs Private Limited has 3 board changes on record since 2009: 2 appointments and 1 cessation. The latest: Kakoli Roy ceased to be Director on 01 Apr 2023.
Frequently asked questions
Sam Marino Labs is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 April 2009 (17+ years old) and is registered under CIN U74900UP2009PTC037115.
Sam Marino Labs has 2 current directors:
- Shahana Afaq - Director
- Garima Sharma - Director
The latest financial statements of Sam Marino Labs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Sam Marino Labs is 05AANCS2181E1ZF, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Sam Marino Labs is U74900UP2009PTC037115. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sam Marino Labs was incorporated on 06 April 2009, making it 17+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Sam Marino Labs by revenue are Pyramid Formulations Private Limited, Inspride Lab Private Limited, Kapsin Pharma Private Limited, Coz Drug Marketing Services Private Limited, Kadam Pharma Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Kakoli Roy ceased to be Director on 01 Apr 2023. Shahana Afaq was appointed as Director on 01 Apr 2023. Garima Sharma was appointed as Director on 06 Apr 2009.
Yes, Sam Marino Labs is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0053386).
The registered office of Sam Marino Labs is at C – 39 Sector – H Aliganj, Lucknow, Uttar Pradesh, India – 226024.
Sam Marino Labs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.